Mike K. Palmer

1.9k total citations · 1 hit paper
26 papers, 1.4k citations indexed

About

Mike K. Palmer is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mike K. Palmer has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mike K. Palmer's work include Lipoproteins and Cardiovascular Health (11 papers), Cardiovascular Health and Disease Prevention (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Mike K. Palmer is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Cardiovascular Health and Disease Prevention (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Mike K. Palmer collaborates with scholars based in United Kingdom, United States and Netherlands. Mike K. Palmer's co-authors include Philip J. Barter, Stephen J. Nicholls, Michiel L. Bots, Joel S. Raichlen, Gunnar Brandrup‐Wognsen, Gregory W. Evans, Diederick E. Grobbee, Daniel H. O’Leary, Ward A. Riley and John R. Crouse and has published in prestigious journals such as JAMA, Circulation and Cancer.

In The Last Decade

Mike K. Palmer

26 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical Atherosclerosis

2007 510 citations John R. Crouse, Joel S. Raichlen et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike K. Palmer United Kingdom	17	745	530	344	322	230	26	1.4k
Jong-Soon Park United States	12	793 1.1×	375 0.7×	632 1.8×	251 0.8×	171 0.7×	27	1.7k
Wendy Hague Australia	19	1.6k 2.1×	628 1.2×	640 1.9×	244 0.8×	236 1.0×	42	2.8k
Zbigniew Gaciong Poland	20	723 1.0×	509 1.0×	300 0.9×	143 0.4×	225 1.0×	82	1.5k
J. C. M. Witteman Netherlands	12	568 0.8×	568 1.1×	324 0.9×	159 0.5×	190 0.8×	17	1.6k
Meral Kayıkçıoğlu Türkiye	22	686 0.9×	931 1.8×	252 0.7×	136 0.4×	131 0.6×	116	1.8k
Kazuhiko Hirobe Russia	17	677 0.9×	516 1.0×	544 1.6×	123 0.4×	119 0.5×	42	1.6k
Devaki Nair United Kingdom	23	708 1.0×	480 0.9×	244 0.7×	326 1.0×	74 0.3×	53	1.8k
Nicholas Marston United States	16	569 0.8×	542 1.0×	303 0.9×	97 0.3×	138 0.6×	49	1.2k
Andrea Zuckerman United States	18	790 1.1×	622 1.2×	832 2.4×	194 0.6×	174 0.8×	32	2.4k

Countries citing papers authored by Mike K. Palmer

Since Specialization

Citations

This map shows the geographic impact of Mike K. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike K. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike K. Palmer more than expected).

Fields of papers citing papers by Mike K. Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike K. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike K. Palmer. The network helps show where Mike K. Palmer may publish in the future.

Co-authorship network of co-authors of Mike K. Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Mike K. Palmer. A scholar is included among the top collaborators of Mike K. Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike K. Palmer. Mike K. Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ballantyne, Christie M., Ron C. Hoogeveen, Joe L. Raya, et al.. (2013). Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study. Atherosclerosis. 232(1). 86–93. 36 indexed citations

Karlson, Björn W., Stephen J. Nicholls, Pia Lundman, Mike K. Palmer, & Philip J. Barter. (2013). Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥50% reduction in high-risk patients: Results from VOYAGER. Atherosclerosis. 228(1). 265–269. 18 indexed citations

Lind, Lars, Sanne A. E. Peters, Hester M. den Ruijter, et al.. (2012). Effect of Rosuvastatin on the Echolucency of the Common Carotid Intima-Media in Low-Risk Individuals: The METEOR Trial. Journal of the American Society of Echocardiography. 25(10). 1120–1127.e1. 19 indexed citations

Peters, Sanne A. E., Michiel L. Bots, Hester M. den Ruijter, et al.. (2012). Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models. Journal of Clinical Epidemiology. 65(6). 686–695. 126 indexed citations

Peters, Sanne A. E., Hester M. den Ruijter, Mike K. Palmer, et al.. (2012). Biologically implausible carotid intima–media thickness measurement values: effects on rate of change over time. Current Medical Research and Opinion. 28(6). 891–899. 3 indexed citations

Peters, Sanne A. E., Mike K. Palmer, Hester M. den Ruijter, et al.. (2012). Sample size requirements in trials using repeated measurements and the impact of trial design. Current Medical Research and Opinion. 28(5). 681–688. 8 indexed citations

Peters, Sanne A. E., Mike K. Palmer, Diederick E. Grobbee, et al.. (2011). Effect of number of ultrasound examinations on the assessment of carotid intima–media thickness changes over time: the example of the METEOR study. Journal of Hypertension. 29(6). 1145–1154. 7 indexed citations

Doğan, Soner, Y. Plantinga, John R. Crouse, et al.. (2011). Algorithms to measure carotid intima–media thickness in trials. Journal of Hypertension. 29(11). 2181–2193. 19 indexed citations

Peters, Sanne A. E., Hester M. den Ruijter, Mike K. Palmer, et al.. (2011). Extensive or Restricted Ultrasound Protocols to Measure Carotid Intima-Media Thickness: Analysis of Completeness Rates and Impact on Observed Rates of Change Over Time. Journal of the American Society of Echocardiography. 25(1). 91–100. 19 indexed citations

10.

Peters, Sanne A. E., Soner Doğan, Rudy Meijer, et al.. (2011). The Use of Plaque Score Measurements to Assess Changes in Atherosclerotic Plaque Burden Induced by Lipid-Lowering Therapy Over Time: The METEOR Study. Journal of Atherosclerosis and Thrombosis. 18(9). 784–795. 20 indexed citations

11.

Nicholls, Stephen J., Gunnar Brandrup‐Wognsen, Mike K. Palmer, & Philip J. Barter. (2009). Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER). The American Journal of Cardiology. 105(1). 69–76. 188 indexed citations

12.

Palmer, Mike K., Andreas Kremer, & Georg C. Terstappen. (2009). A Primer on Screening Data Management. SLAS DISCOVERY. 14(8). 999–1007. 1 indexed citations

13.

Thakor, Avnesh S., et al.. (2009). Toxic epidermal necrolysis and neutropaenia: Complications of omeprazole. Australasian Journal of Dermatology. 50(3). 207–210. 15 indexed citations

14.

Barter, Philip J., Gunnar Brandrup‐Wognsen, Mike K. Palmer, & Stephen J. Nicholls. (2009). Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. Journal of Lipid Research. 51(6). 1546–1553. 195 indexed citations

15.

Bots, Michiel L., Joel S. Raichlen, Gregory W. Evans, et al.. (2007). Abstract 194: Rosuvastatin Reduces Progression of Carotid Atherosclerosis within 12 Months of Treatment: The METEOR Trial. Circulation. 116(suppl_16). 2 indexed citations

16.

Crouse, John R., Joel S. Raichlen, Ward A. Riley, et al.. (2007). Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical Atherosclerosis. JAMA. 297(12). 1344–1344. 510 indexed citations breakdown →

17.

Crouse, John R., Diederick E. Grobbee, Daniel H. O’Leary, et al.. (2007). Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study. Current Medical Research and Opinion. 23(3). 641–648. 19 indexed citations

18.

Crouse, John R., Diederick E. Grobbee, Daniel H. O’Leary, et al.. (2004). Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study. Cardiovascular Drugs and Therapy. 18(3). 231–238. 65 indexed citations

19.

Palmer, Mike K.. (2002). How an effective project culture can help to achieve business success: establishing a project culture in Kimberly‐Clark Europe. Industrial and Commercial Training. 34(3). 101–105. 12 indexed citations

20.

Thatcher, Nicholas, John Wagstaff, P M Wilkinson, Mike K. Palmer, & Derek Crowther. (1982). Intermittent high-dose cyclophosphamide with and without prednisolone. A study of the relationships between toxicity, response and survival in metastatic lung cancer. Cancer. 50(6). 1051–1056. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact